Oncolytic virotherapy offers new approach in treating brain tumors
For Jennifer Amsley and daughter Xia Martinez of Maryland, an oncolytic virotherapy study at Children ’s of Alabama has strengthened their resolve to fight and their desire for a sense of normalcy.
Xia, 14, has an aggressive glioma brain tumor and an MRI showed new growth. That’s when doctors in Maryland informed Xia and her family of a clinical trial conducted by Dr. Gregory Friedman, associat e professor of pediatrics at the University of Alabama at Birmingham (UAB) and Children’s, and scientist… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 1, 2017 Category: Biotechnology Authors: Content provided by Children ’s of Alabama Source Type: news
Childhood Brain Stem Glioma Treatment
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 31, 2017 Category: General Medicine Source Type: news
Nanotech derived from amniotic stem cells could help treat brain cancer
Creative Medical Technology Holdings (OTC:CELZ) touted its exosome technology today, reporting that it demonstrated an ability to regenerate healthy brain cells while selectively halting the growth of glioma brain cancer cells in a preclinical model.
The company’s exosomes are vesicles harvested from amniotic stem cell technology, which it licensed from the University of California San Diego in an exclusive deal for the AmnioStem platform.
Get the full story at our sister site, Drug Delivery Business News.
The post Nanotech derived from amniotic stem cells could help treat brain cancer appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 26, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Neurological Oncology Research & Development Stent Grafts Wall Street Beat creativemedicaltechnologyholdings University of California at San Diego Source Type: news
Tocagen Receives European Medicines Agency Priority Medicines (PRIME) Designation for Toca 511 in High Grade Glioma
SAN DIEGO, July 24, 2017 -- (Healthcare Sales & Marketing Network) -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the European Medicines Agency (EMA) has granted Toca 511 (vocimagene amiretrorepvec... Biopharmaceuticals, Oncology, Regulatory Tocagen, Toca 511, glioma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 24, 2017 Category: Pharmaceuticals Source Type: news
Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance
(University of Alabama at Birmingham) A collaborative team of neuro-oncology surgeon/scientists -- led by Ichiro Nakano, M.D., Ph.D., University of Alabama at Birmingham, and Maode Wang, M.D., Xi'an Jiaotong University, Xi'an, China -- has discovered a unique and previously unidentified molecular mechanism that maintains glioma stem cells, and they have tested it as a potential therapeutic target in glioblastoma, using a novel small molecule inhibitor they designed and synthesized (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 24, 2017 Category: Cancer & Oncology Source Type: news
Addy Sooter headed to Mexico for treatment for brain tumor
Addy Sooter, who lives in Rogers, Arkansas, was diagnosed with a diffuse intrinsic pontine glioma (DIPG) brain tumor in November 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2017 Category: Consumer Health News Source Type: news
Girl headed to Mexico for at treatment for brain tumor
Addy Sooter, who lives in Rogers, Arkansas, was diagnosed with a diffuse intrinsic pontine glioma (DIPG) brain tumor in November 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - July 18, 2017 Category: Consumer Health News Source Type: news
FDA Approves Fluorescing Agent for Glioma Surgery
The US Food and Drug Administration has approved the optical imaging agent aminolevulinic acid hydrochloride to enhance visualization of malignant tissue during surgery for gliomas. (Source: CancerNetwork)
Source: CancerNetwork - June 28, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Brain Tumors News Source Type: news
Concussion researcher nets $25M for CTE program
Noted concussion researcher Dr. Julian Bailes has been awarded new grant...Read more on AuntMinnie.comRelated Reading:
SNMMI: FET-PET could have answers for brainstem glioma
SNMMI: PET can detect which plaques are at risk of rupture
SNMMI partners with NDSC on appropriate use criteria
SNMMI offers appropriate use criteria for 2 cancers
SNMMI to Trump: Rescind travel ban (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 12, 2017 Category: Radiology Source Type: news
SNMMI: FET-PET could have answers for brainstem glioma
DENVER - Researchers in Switzerland are setting their sights on fluoroethyl-tyrosine...Read more on AuntMinnie.comRelated Reading:
PET identifies cell mutations in NSCLC patients
Novel PET tracer aids recurrent prostate cancer patients
PET/CT CAD finds common spinal metastases
PiB-PET could open window on common meningiomas
ASTRO: PET predicts outcomes in vulvar cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 12, 2017 Category: Radiology Source Type: news
Parents share video of their daughter's dying moments
Katie King, from California, died in June 2016 from Diffuse Intrinsic Pontic Glioma. Her mother Jaime has shared this video to make people understand the true horror of the hopeless disease. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2017 Category: Consumer Health News Source Type: news
FDA OKs Gleolan, First Fluorescing Agent for Glioma Surgery FDA OKs Gleolan, First Fluorescing Agent for Glioma Surgery
Gleolan oral solution (aminolevulinic acid hydrochloride) enhances the visualization of malignant tissue during glioma surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas
June 6, 2017 - The U.S. Food and Drug Administration (FDA) has approved Gleolan [aminolevulinic acid hydrochloride (ALA HCl)] as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization Grades III or IV on... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 6, 2017 Category: Drugs & Pharmacology Source Type: news
New target found to attack an incurable brain tumor in children
(Ann& Robert H. Lurie Children's Hospital of Chicago) Research shows that a tumor suppressor gene p16 is turned off by a histone mutation (H3.3K27M), which is found in up to 70 percent of childhood brain tumors called diffuse intrinsic pontine glioma (DIPG). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2017 Category: International Medicine & Public Health Source Type: news
Texas girl died five days after brain cancer diagnosis
Jade Bridier, from Bryan, Texas, was diagnosed with a rare brain tumor, called diffuse intrinsic pontine glioma (DIPG) in August. She died just five days after her diagnosis at four years old. (Source: the Mail online | Health)
Source: the Mail online | Health - May 30, 2017 Category: Consumer Health News Source Type: news
